BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29408906)

  • 1. Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials.
    Dai YK; Li DY; Zhang YZ; Huang MX; Zhou YL; Ye JT; Wang Q; Hu L
    PLoS One; 2018; 13(2):e0192319. PubMed ID: 29408906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials.
    Liang SB; Cao HJ; Kong LY; Wei JL; Robinson N; Yang SH; Zhu SJ; Li YQ; Fei YT; Han M; Liu JP
    Front Pharmacol; 2022; 13():904657. PubMed ID: 36091782
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of systematic evaluation of efficacy of Tongxie Yaofang in treating diarrhea-predominant irritable bowel syndrome.
    Chen X; Yu X; Shi Y; Shen H
    Ann Palliat Med; 2021 Aug; 10(8):9223-9232. PubMed ID: 34488410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acupuncture plus Chinese Herbal Medicine for Irritable Bowel Syndrome with Diarrhea: A Systematic Review and Meta-Analysis.
    Yan J; Miao ZW; Lu J; Ge F; Yu LH; Shang WB; Liu LN; Sun ZG
    Evid Based Complement Alternat Med; 2019; 2019():7680963. PubMed ID: 31110553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of Shugan Jianpi Zhixie therapy for diarrhea-predominant irritable bowel syndrome: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Xiao Y; Liu Y; Huang S; Sun X; Tang Y; Cheng J; Wang T; Li F; Kuang Y; Luo R; Zhao X
    PLoS One; 2015; 10(4):e0122397. PubMed ID: 25853241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome: A protocol for meta-analysis.
    Li YL; Yao CJ; Lei R; Xie F; Xiong Q; Luo LH; Feng PM
    Medicine (Baltimore); 2020 Nov; 99(48):e23457. PubMed ID: 33235133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Tongxie-Yaofang Regulates Intestinal Synaptic Plasticity by Activating Enteric Glial Cells and NGF/TrkA Pathway in Diarrhea-Predominant Irritable Bowel Syndrome Rats.
    Lu X; Zhang S
    Drug Des Devel Ther; 2023; 17():2969-2983. PubMed ID: 37789966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N; Li J; Wang Y; Zhang S
    J Ethnopharmacol; 2023 Dec; 317():116672. PubMed ID: 37328079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Shenlingbaizhu formula on irritable bowel syndrome: a systematic review.
    Wang Y; Zhang S; Zhou Q; Meng M; Chen W
    J Tradit Chin Med; 2020 Dec; 40(6):897-907. PubMed ID: 33258340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review.
    Bian Z; Wu T; Liu L; Miao J; Wong H; Song L; Sung JJ
    J Altern Complement Med; 2006 May; 12(4):401-7. PubMed ID: 16722791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupoint application therapy for diarrhea-predominant irritable bowel syndrome: a protocol for systematic review and network meta-analysis.
    Yin X; Li S; Ouyang M; Ou R; Chen Z; Wei S; Huang H; Liu D
    Ann Palliat Med; 2022 Dec; 11(12):3785-3793. PubMed ID: 36510459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating effect of TongXie-YaoFang on colonic epithelial secretion
    Yang C; Xiong Y; Zhang SS; An FM; Sun J; Zhang QL; Zhan Q
    World J Gastroenterol; 2016 Dec; 22(48):10584-10591. PubMed ID: 28082810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Tongxie Yaofang Granule in treating diarrhea-predominate irritable bowel syndrome.
    Pan F; Zhang T; Zhang YH; Xu JJ; Chen FM
    Chin J Integr Med; 2009 Jun; 15(3):216-9. PubMed ID: 19568715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of herb-partitioned moxibustion for diarrhoea-predominant irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Wang F; He S; Yan J; Mai L; Yang L
    Medicine (Baltimore); 2020 Aug; 99(34):e21817. PubMed ID: 32846822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Zhishixiaopi decoction in functional dyspepsia: A meta-analysis of randomized controlled trials.
    Zhao X; Cheng X; Ye J; Ren J; Li B; Tan D; Li T; Zhou K; Pu J; Luo X; Feng Y
    PLoS One; 2024; 19(5):e0301686. PubMed ID: 38809916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acupuncture for diarrhea-predominant irritable bowel syndrome:a meta-analysis].
    Deng D; Guo K; Tan J; Huang G; Li S; Jiang Q; Xie J; Xie H; Zhang Z; Chen Y; Peng L
    Zhongguo Zhen Jiu; 2017 Aug; 37(8):907-912. PubMed ID: 29231356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of TongXie-YaoFang formula on colonic contraction in rats.
    Yang C; Zhang SS; Li XL; Wang ZF; Zhao LQ
    World J Gastroenterol; 2015 Mar; 21(10):2912-7. PubMed ID: 25780288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evidence of acupuncture and moxibustion for irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Yang Y; Rao K; Zhan K; Shen M; Zheng H; Qin S; Wu H; Bian Z; Huang S
    Front Public Health; 2022; 10():1022145. PubMed ID: 36589968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.